Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | L lactate dehydrogenase B chain | 0.029 | 1 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0156 | 0.2438 | 0.2438 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.029 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0156 | 0.2438 | 1 |
Plasmodium falciparum | L-lactate dehydrogenase | 0.029 | 1 | 1 |
Mycobacterium tuberculosis | Probable malate dehydrogenase Mdh | 0.0113 | 0 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0156 | 0.2438 | 1 |
Plasmodium vivax | malate dehydrogenase, putative | 0.029 | 1 | 1 |
Schistosoma mansoni | L-lactate dehydrogenase | 0.029 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.029 | 1 | 0.5 |
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.029 | 1 | 1 |
Schistosoma mansoni | malate dehydrogenase | 0.029 | 1 | 1 |
Echinococcus granulosus | L lactate dehydrogenase | 0.0177 | 0.3641 | 0.3641 |
Chlamydia trachomatis | malate dehydrogenase | 0.0113 | 0 | 0.5 |
Echinococcus multilocularis | L lactate dehydrogenase | 0.0177 | 0.3641 | 0.3641 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0156 | 0.2438 | 0.2438 |
Echinococcus granulosus | lactate dehydrogenase protein | 0.029 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0156 | 0.2438 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0156 | 0.2438 | 0.2438 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0156 | 0.2438 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0156 | 0.2438 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0156 | 0.2438 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0156 | 0.2438 | 1 |
Plasmodium vivax | lactate dehydrogenase | 0.029 | 1 | 1 |
Echinococcus multilocularis | L lactate dehydrogenase B chain | 0.029 | 1 | 1 |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.029 | 1 | 1 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.029 | 1 | 1 |
Echinococcus granulosus | lactate dehydrogenase a | 0.029 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 1 | 1 |
Plasmodium falciparum | malate dehydrogenase | 0.029 | 1 | 1 |
Leishmania major | malate dehydrogenase, putative | 0.029 | 1 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0156 | 0.2438 | 0.2438 |
Mycobacterium leprae | PROBABLE MALATE DEHYDROGENASE MDH | 0.0113 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0156 | 0.2438 | 1 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.029 | 1 | 1 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.029 | 1 | 1 |
Mycobacterium ulcerans | malate dehydrogenase | 0.0113 | 0 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0156 | 0.2438 | 0.2438 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0156 | 0.2438 | 1 |
Echinococcus multilocularis | lactate dehydrogenase protein | 0.029 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0156 | 0.2438 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.0156 | 0.2438 | 0.2438 |
Echinococcus granulosus | lactate dehydrogenase a | 0.029 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0156 | 0.2438 | 0.2438 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0156 | 0.2438 | 0.2438 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.029 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0156 | 0.2438 | 0.2438 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0156 | 0.2438 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.